← All trials
NCT00201344
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 1994
- Primary completion
- —
- Completion date
- Jan 1, 2000
- First posted
- —
- Last posted
- —
- Enrollment
- 320
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Government of TaiwanLead sponsor
- Kaohsiung Medical UniversityCollaborator
- National Taiwan UniversityCollaborator
- Government of TaiwanCollaborator
- Taichung Veterans General HospitalCollaborator
- Taipei Veteran General hospitalCollaborator
- Taiwan Cooperative Oncology GroupOverall official - principal investigator
- Mackay Medical CollegeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.